An immunohistochemical study on the distribution and frequency of T regulatory cells in pancreatic islets of NOD mice during various stages of spontaneous and cyclophosphamide-accelerated diabetes

Pancreas

Volumn 39, Issue 7, 2010, Pages 1024-1033

  Kaur, Sarbjot ^a   Tan, Wan Ling ^a   Soo, Camelia ^a   Cheung, Carlos Chun Ho ^a   Stewart, Joanna ^b   Reddy, Shiva ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

diabetes; Foxp3; immunoregulation; islet; T regulatory cells

Indexed keywords

CYCLOPHOSPHAMIDE; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FREQUENCY ANALYSIS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; CYCLOPHOSPHAMIDE; DIABETES MELLITUS; FEMALE; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; T-LYMPHOCYTES, REGULATORY;

EID: 77957729952     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181da9037     Document Type: Article

References (34)

1. Mathis D, Vence L, Benoist C. β-Cell death during progression to diabetes. Nature. 2001;414:792-798.
2. Eisenbarth GS, Connelly J, Soeldner JS. The "natural history" of type 1 diabetes. Diabetes Metab Rev. 1987;3:873-891.
3. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol. 1992;51:285-322.
4. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221-229.
5. Andre I, Gonzalez B, Wang B, et al. Checkpoints in the progression of autoimmune diabetes: lessons from diabetes models. Proc Natl Acad Sci U S A. 1996;93:2260-2263.
6. + regulatory T cells control autoimmunity? Curr Opin Immunol. 2005;17:638-642.
7. Tang Q, Bluestone JA. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev. 2006;212:217-237.
8. Reddy S, Wu D, Swinney C, et al. Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Pancreas. 1995;11:16-25.
9. Levings MK, Allan S, d'Hennezal E, et al. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv Immunol. 2006;92:119-155.
10. Wong FS, Dayan CM. Regulatory T cells in autoimmune endocrine diseases. Trends Endocrinol Metab. 2008;19:292-299.
11. Gregori S, Giarratana N, Smiroldo S, et al. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol. 2003;171:4040-4047.
12. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151-1164.
13. Sakaguchi S. Regulatory T cells: controllers of immunological self-tolerance. Cell. 200;101:455-458.
14. Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science. 2007;317:627-629.
15. + regulatory T cells during autoimmune diabetes. J Exp Med. 2005;201:1333-1346.
16. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000;12:431-440.
17. + T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci U S A. 2003;100:10878-10883.
18. + regulatory T cells. Immunology. 2007;121:15-28.
19. + regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes. 2008;57:113-123.
20. You S, Belghith M, Cobbold S, et al. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes. 2005;54:1415-1422.
21. Tang Q, Adams JY, Penaranda C, et al. Central role of a defective interleukin-2 production in triggering islet autoimmune destruction. Immunity. 2008;28:687-697.
22. Bai Y, Robinson E, Chai R, et al. Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes. J Mol Hist. 2006;37:101-113.
23. + regulatory T cells. J Immunol. 2006;177:6603-6612.
24. Korn T, Reddy J, Gao W, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nature Med. 2007;13:423-431.
25. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behaviour in vitro. Proc Natl Acad Sci U S A. 2003;100:8886-8891.
26. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol. 2005;6:338-344.
27. Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523-532.
28. Bach JF. Regulatory T cells under scrutiny. Nat Rev Immunol. 2003; 3:189-198.
29. Harada M, Makino S. Promotion of spontaneous diabetes in non-obese diabetese-prone mice by cyclophosphamide. Diabetologia. 1984;27:604-606.
30. Reddy S, Yip S, Karanam M, et al. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide. Histochem J. 1999;31:303-314.
31. Reddy S, Karanam M, Poole CA, et al. Dual-label immunohistochemistry of interleukin-4- and interferon-F-expressing cells within the pancreas of the NOD mouse during disease acceleration with cyclophosphamide. Autoimmunity. 2000;32:181-192.
32. Reddy S, Young M, Ginn S. Immunoexpression of interleukin-1A in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes: co-localization in macrophages and endocrine cells and its attenuation with oral nicotinamide. Histochem J. 2001;33:317-327.
33. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med. 2004;199:1479-1489.
34. + T reg cells impinge on autoimmune diabetes. J Exp Med. 2005;202:1387-1397.